{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:48:37Z","timestamp":1793130517032,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10633-023-09945-8","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T05:01:51Z","timestamp":1690606911000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Retinal dysfunction in Parkinson\u2019s disease\u2014results of the extended protocol for photopic negative response (PHNR) full-field electroretinogram (ERG)"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-4941","authenticated-orcid":false,"given":"Osman Ahmet","family":"Polat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-4269","authenticated-orcid":false,"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-0170","authenticated-orcid":false,"given":"Hidayet","family":"Sener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-9582","authenticated-orcid":false,"given":"Furkan","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-2490","authenticated-orcid":false,"given":"Hatice","family":"Arda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"9945_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","volume":"64","author":"A Chrysou","year":"2019","unstructured":"Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson\u2019s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40\u201349. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.023","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"9945_CR2","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1212\/WNL.0000000000006157","volume":"91","author":"J Ahn","year":"2018","unstructured":"Ahn J, Lee JY, Kim TW, Yoon EJ, Oh S, Kim YK et al (2018) Retinal thinning associates with Nigral dopaminergic loss in de novo Parkinson disease. Neurology 91(11):e1003\u2013e1012. https:\/\/doi.org\/10.1212\/WNL.0000000000006157","journal-title":"Neurology"},{"issue":"2","key":"9945_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1167\/iovs.16-20460","volume":"58","author":"M Satue","year":"2017","unstructured":"Satue M, Rodrigo MJ, Obis J, Vilades E, Gracia H, Otin S et al (2017) Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson\u2019s disease. Invest Ophthalmol Vis Sci 58(2):1151\u20131157. https:\/\/doi.org\/10.1167\/iovs.16-20460","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9945_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/WNO.0000000000000240","volume":"35","author":"M Kaur","year":"2015","unstructured":"Kaur M, Saxena R, Singh D, Behari M, Sharma P, Menon V (2015) Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol 35(3):254\u2013258. https:\/\/doi.org\/10.1097\/WNO.0000000000000240","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"9945_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.25897","volume":"88","author":"I Ortuno-Lizaran","year":"2020","unstructured":"Ortuno-Lizaran I, Sanchez-Saez X, Lax P, Serrano GE, Beach TG, Adler CH et al (2020) Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease. Ann Neurol 88(5):893\u2013906. https:\/\/doi.org\/10.1002\/ana.25897","journal-title":"Ann Neurol"},{"issue":"8","key":"9945_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortuno-Lizaran","year":"2018","unstructured":"Ortuno-Lizaran I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N (2018) Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov Disord 33(8):1315\u20131324. https:\/\/doi.org\/10.1002\/mds.27392","journal-title":"Mov Disord"},{"issue":"3","key":"9945_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","volume":"137","author":"L Veys","year":"2019","unstructured":"Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L et al (2019) Retinal alpha-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathol 137(3):379\u2013395. https:\/\/doi.org\/10.1007\/s00401-018-01956-z","journal-title":"Acta Neuropathol"},{"key":"9945_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fneur.2017.00710","volume":"8","author":"C La Morgia","year":"2017","unstructured":"La Morgia C, Di Vito L, Carelli V, Carbonelli M (2017) Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs magnocellular degeneration in optical coherence tomography studies. Front Neurol 8:710. https:\/\/doi.org\/10.3389\/fneur.2017.00710","journal-title":"Front Neurol"},{"issue":"11","key":"9945_CR9","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1007\/s00415-020-10094-0","volume":"268","author":"L Huang","year":"2021","unstructured":"Huang L, Wang C, Wang W, Wang Y, Zhang R (2021) The specific pattern of retinal nerve fiber layer thinning in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol 268(11):4023\u20134032. https:\/\/doi.org\/10.1007\/s00415-020-10094-0","journal-title":"J Neurol"},{"key":"9945_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2016.07.004","volume":"31","author":"T Ucak","year":"2016","unstructured":"Ucak T, Alagoz A, Cakir B, Celik E, Bozkurt E, Alagoz G (2016) Analysis of the retinal nerve fiber and ganglion cell\u2014inner plexiform layer by optical coherence tomography in Parkinson\u2019s patients. Parkinsonism Relat Disord 31:59\u201364. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9945_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0168-5597(95)00169-7","volume":"100","author":"M Tagliati","year":"1996","unstructured":"Tagliati M, Bodis-Wollner I, Yahr MD (1996) The pattern electroretinogram in Parkinson\u2019s disease reveals lack of retinal spatial tuning. Electroencephalograph Clin Neurophysiol\/Evoked Potentials Section 100(1):1\u201311. https:\/\/doi.org\/10.1016\/0168-5597(95)00169-7","journal-title":"Electroencephalograph Clin Neurophysiol\/Evoked Potentials Section"},{"issue":"6","key":"9945_CR12","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/wnl.45.6.1144","volume":"45","author":"A Peppe","year":"1995","unstructured":"Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G (1995) Visual alterations in de novo Parkinson\u2019s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 45(6):1144\u20131148. https:\/\/doi.org\/10.1212\/wnl.45.6.1144","journal-title":"Neurology"},{"issue":"10","key":"9945_CR13","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1167\/iovs.07-0218","volume":"48","author":"NV Rangaswamy","year":"2007","unstructured":"Rangaswamy NV, Shirato S, Kaneko M, Digby BI, Robson JG, Frishman LJ (2007) Effects of spectral characteristics of ganzfeld stimuli on the photopic negative response (PhNR) of the ERG. Invest Ophthalmol Vis Sci 48(10):4818\u20134828. https:\/\/doi.org\/10.1167\/iovs.07-0218","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9945_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10633-018-9638-x","volume":"136","author":"L Frishman","year":"2018","unstructured":"Frishman L, Sustar M, Kremers J, McAnany JJ, Sarossy M, Tzekov R et al (2018) ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol 136(3):207\u2013211. https:\/\/doi.org\/10.1007\/s10633-018-9638-x","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"9945_CR15","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1038\/s41598-021-85010-1","volume":"11","author":"S Asanad","year":"2021","unstructured":"Asanad S, Felix CM, Fantini M, Harrington MG, Sadun AA, Karanjia R (2021) Retinal ganglion cell dysfunction in preclinical Alzheimer\u2019s disease: an electrophysiologic biomarker signature. Sci Rep 11(1):6344. https:\/\/doi.org\/10.1038\/s41598-021-85010-1","journal-title":"Sci Rep"},{"issue":"6","key":"9945_CR16","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1167\/iovs.15-16586","volume":"56","author":"HE Moss","year":"2015","unstructured":"Moss HE, Park JC, McAnany JJ (2015) The photopic negative response in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56(6):3709\u20133714. https:\/\/doi.org\/10.1167\/iovs.15-16586","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9945_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/397178","author":"S Machida","year":"2012","unstructured":"Machida S (2012) Clinical applications of the photopic negative response to optic nerve and retinal diseases. J Ophthalmol. https:\/\/doi.org\/10.1155\/2012\/397178","journal-title":"J Ophthalmol"},{"issue":"3","key":"9945_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/archopht.122.3.341","volume":"122","author":"Y Gotoh","year":"2004","unstructured":"Gotoh Y, Machida S, Tazawa Y (2004) Selective loss of the photopic negative response in patients with opticnerve atrophy. Arch Ophthalmol 122(3):341\u2013346. https:\/\/doi.org\/10.1001\/archopht.122.3.341","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"9945_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","volume":"6","author":"I Ortuno-Lizaran","year":"2018","unstructured":"Ortuno-Lizaran I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P et al (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson\u2019s disease. Acta Neuropathol Commun 6(1):90. https:\/\/doi.org\/10.1186\/s40478-018-0596-z","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"9945_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3892\/etm.2021.10244","volume":"22","author":"S Diaconu","year":"2021","unstructured":"Diaconu S, Falup-Pecurariu O, Tint D, Falup-Pecurariu C (2021) REM sleep behaviour disorder in Parkinson\u2019s disease (review). Exp Ther Med 22(2):812. https:\/\/doi.org\/10.3892\/etm.2021.10244","journal-title":"Exp Ther Med"},{"issue":"1","key":"9945_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10072-016-2744-1","volume":"38","author":"X Zhang","year":"2017","unstructured":"Zhang X, Sun X, Wang J, Tang L, Xie A (2017) Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson\u2019s disease: a meta and meta-regression analysis. Neurol Sci 38(1):163\u2013170. https:\/\/doi.org\/10.1007\/s10072-016-2744-1","journal-title":"Neurol Sci"},{"issue":"11","key":"9945_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1212\/WNL.0b013e31822e560e","volume":"77","author":"F Sixel-D\u00f6ring","year":"2011","unstructured":"Sixel-D\u00f6ring F, Trautmann E, Mollenhauer B, Trenkwalder C (2011) Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 77(11):1048\u20131054. https:\/\/doi.org\/10.1212\/WNL.0b013e31822e560e","journal-title":"Neurology"},{"issue":"2","key":"9945_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.sleep.2004.01.003","volume":"5","author":"G Plazzi","year":"2004","unstructured":"Plazzi G (2004) REM sleep behavior disorders in Parkinson\u2019s disease and other Parkinsonian disorders. Sleep Med 5(2):195\u2013199. https:\/\/doi.org\/10.1016\/j.sleep.2004.01.003","journal-title":"Sleep Med"},{"key":"9945_CR24","doi-asserted-by":"publisher","unstructured":"Bhidayasiri R, Tarsy D. Parkinson\u2019s disease: Hoehn and Yahr scale. Movement disorders: a video Atlas. Springer; 2012. p. 4\u20135. https:\/\/doi.org\/10.1007\/978-1-60327-426-5_2","DOI":"10.1007\/978-1-60327-426-5_2"},{"issue":"16","key":"9945_CR25","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire\u2013a new diagnostic instrument. Mov Disord 22(16):2386\u20132393. https:\/\/doi.org\/10.1002\/mds.21740","journal-title":"Mov Disord"},{"issue":"17","key":"9945_CR26","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.visres.2005.02.010","volume":"45","author":"M Rufiange","year":"2005","unstructured":"Rufiange M, Dumont M, Lachapelle P (2005) Modulation of the human photopic ERG luminance-response function with the use of chromatic stimuli. Vision Res 45(17):2321\u20132330. https:\/\/doi.org\/10.1016\/j.visres.2005.02.010","journal-title":"Vision Res"},{"issue":"12","key":"9945_CR27","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s10792-020-01515-0","volume":"40","author":"M Prencipe","year":"2020","unstructured":"Prencipe M, Perossini T, Brancoli G, Perossini M (2020) The photopic negative response (PhNR): measurement approaches and utility in glaucoma. Int Ophthalmol 40(12):3565\u20133576. https:\/\/doi.org\/10.1007\/s10792-020-01515-0","journal-title":"Int Ophthalmol"},{"key":"9945_CR28","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/908306","author":"RA Armstrong","year":"2011","unstructured":"Armstrong RA (2011) Visual symptoms in Parkinson\u2019s disease. Parkinsons Dis. https:\/\/doi.org\/10.4061\/2011\/908306","journal-title":"Parkinsons Dis"},{"key":"9945_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2020.100018","volume":"2","author":"SM Silverstein","year":"2020","unstructured":"Silverstein SM, Demmin DL, Schallek JB, Fradkin SI (2020) Measures of retinal structure and function as biomarkers in neurology and psychiatry. Biomark Neuropsych 2:100018.\u00a0https:\/\/doi.org\/10.1016\/j.bionps.2020.100018","journal-title":"Biomark Neuropsych"},{"issue":"2","key":"9945_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","volume":"131","author":"B Nowacka","year":"2015","unstructured":"Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson\u2019s disease (PD). Doc Ophthalmol 131(2):95\u2013104. https:\/\/doi.org\/10.1007\/s10633-015-9503-0","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"9945_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF02821713","volume":"19","author":"J Nguyen-Legros","year":"1999","unstructured":"Nguyen-Legros J, Versaux-Botteri C, Vernier P (1999) Dopamine receptor localization in the mammalian retina. Mol Neurobiol 19(3):181\u2013204. https:\/\/doi.org\/10.1007\/BF02821713","journal-title":"Mol Neurobiol"},{"issue":"2","key":"9945_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","volume":"131","author":"B Nowacka","year":"2015","unstructured":"Nowacka B, Lubi\u0144ski W, Honczarenko K, Potemkowski A, Safranow K (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson\u2019s disease (PD). Doc Ophthalmol 131(2):95\u2013104. https:\/\/doi.org\/10.1007\/s10633-015-9503-0","journal-title":"Doc Ophthalmol"},{"issue":"19","key":"9945_CR33","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/0042-6989(94)90248-8","volume":"34","author":"H Ikeda","year":"1994","unstructured":"Ikeda H, Head G, Ellis CK (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson\u2019s disease and a follow up study. Vision Res 34(19):2629\u20132638. https:\/\/doi.org\/10.1016\/0042-6989(94)90248-8","journal-title":"Vision Res"},{"key":"9945_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2022.06.018","volume":"101","author":"LGM Mello","year":"2022","unstructured":"Mello LGM, Paraguay IBB, Andrade TS, Rocha A, Barbosa ER, Oyamada MK et al (2022) Electroretinography reveals retinal dysfunction in Parkinson\u2019s disease despite normal high-resolution optical coherence tomography findings. Parkinsonism Relat Disord 101:90\u201395. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.06.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"9945_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/bmjopen-2015-009658","volume":"6","author":"V Polo","year":"2016","unstructured":"Polo V, Satue M, Rodrigo MJ, Otin S, Alarcia R, Bambo MP et al (2016) Visual dysfunction and its correlation with retinal changes in patients with Parkinson\u2019s disease: an observational cross-sectional study. BMJ Open 6(5):58. https:\/\/doi.org\/10.1136\/bmjopen-2015-009658","journal-title":"BMJ Open"},{"issue":"12","key":"9945_CR36","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1007\/s00415-020-10304-9","volume":"268","author":"L Huang","year":"2021","unstructured":"Huang L, Zhang D, Ji J, Wang Y, Zhang R (2021) Central retina changes in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol 268(12):4646\u20134654. https:\/\/doi.org\/10.1007\/s00415-020-10304-9","journal-title":"J Neurol"},{"issue":"3","key":"9945_CR37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ene.14613","volume":"28","author":"WC Zhou","year":"2021","unstructured":"Zhou WC, Tao JX, Li J (2021) Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: A systematic review and meta-analysis. Eur J Neurol 28(3):763\u2013774. https:\/\/doi.org\/10.1111\/ene.14613","journal-title":"Eur J Neurol"},{"issue":"2","key":"9945_CR38","doi-asserted-by":"publisher","first-page":"470-8 e2","DOI":"10.1016\/j.ajo.2013.09.028","volume":"157","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R et al (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470\u20138 e2. https:\/\/doi.org\/10.1016\/j.ajo.2013.09.028","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"9945_CR39","doi-asserted-by":"publisher","first-page":"e34891","DOI":"10.1371\/journal.pone.0034891","volume":"7","author":"P Albrecht","year":"2012","unstructured":"Albrecht P, Muller AK, Sudmeyer M, Ferrea S, Ringelstein M, Cohn E et al (2012) Optical coherence tomography in parkinsonian syndromes. PLoS ONE 7(4):e34891. https:\/\/doi.org\/10.1371\/journal.pone.0034891","journal-title":"PLoS ONE"},{"issue":"6","key":"9945_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) alpha-synuclein in the inner retina in parkinson disease. Ann Neurol 75(6):964\u2013966. https:\/\/doi.org\/10.1002\/ana.24182","journal-title":"Ann Neurol"},{"issue":"5","key":"9945_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","volume":"71","author":"DP Breen","year":"2014","unstructured":"Breen DP, Vuono R, Nawarathna U, Fisher K, Shneerson JM, Reddy AB et al (2014) Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol 71(5):589\u2013595. https:\/\/doi.org\/10.1001\/jamaneurol.2014.65","journal-title":"JAMA Neurol"},{"issue":"1","key":"9945_CR42","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1038\/s41598-018-26078-0","volume":"8","author":"DS Joyce","year":"2018","unstructured":"Joyce DS, Feigl B, Kerr G, Roeder L, Zele AJ (2018) Melanopsin-mediated pupil function is impaired in Parkinson\u2019s disease. Sci Rep 8(1):7796. https:\/\/doi.org\/10.1038\/s41598-018-26078-0","journal-title":"Sci Rep"},{"issue":"2","key":"9945_CR43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1523\/JNEUROSCI.20-02-00600.2000","volume":"20","author":"I Provencio","year":"2000","unstructured":"Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD (2000) A novel human opsin in the inner retina. J Neurosci 20(2):600\u2013605. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-02-00600.2000","journal-title":"J Neurosci"},{"key":"9945_CR44","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fneur.2018.01000","volume":"9","author":"LA Ostrin","year":"2018","unstructured":"Ostrin LA, Strang CE, Chang K, Jnawali A, Hung LF, Arumugam B et al (2018) Immunotoxin-induced ablation of the intrinsically photosensitive retinal ganglion cells in rhesus monkeys. Front Neurol 9:1000. https:\/\/doi.org\/10.3389\/fneur.2018.01000","journal-title":"Front Neurol"},{"issue":"9","key":"9945_CR45","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 5(9):1315\u20131316. https:\/\/doi.org\/10.1097\/JTO.0b013e3181ec173d","journal-title":"J Thorac Oncol"},{"issue":"5","key":"9945_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00359-014-0906-2","volume":"200","author":"E Popova","year":"2014","unstructured":"Popova E (2014) Role of dopamine in distal retina. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 200(5):333\u2013358. https:\/\/doi.org\/10.1007\/s00359-014-0906-2","journal-title":"J Comp Physiol A Neuroethol Sens Neural Behav Physiol"},{"key":"9945_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40662-016-0064-4","volume":"3","author":"E Popova","year":"2016","unstructured":"Popova E, Kostov M, Kupenova P (2016) Effects of dopamine D(1) receptor blockade on the ERG b- and d-waves during blockade of ionotropic GABA receptors. Eye Vis 3:32. https:\/\/doi.org\/10.1186\/s40662-016-0064-4","journal-title":"Eye Vis"},{"issue":"19","key":"9945_CR48","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/0042-6989(94)90248-8","volume":"34","author":"H Ikeda","year":"1994","unstructured":"Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson\u2019s disease and a follow up study. Vis Res 34(19):2629\u20132638. https:\/\/doi.org\/10.1016\/0042-6989(94)90248-8","journal-title":"Vis Res"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-023-09945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-023-09945-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-023-09945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T02:04:19Z","timestamp":1693447459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-023-09945-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["9945"],"URL":"https:\/\/doi.org\/10.1007\/s10633-023-09945-8","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in human participants were in accordance with the ethical standards of the Erciyes University Local Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Study protocol was approved by Erciyes University Local Ethics Committee (No: 2021\/566).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <b>Statement on the welfare of animals<\/b>: No animals were used in this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"No animals were used in this research.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}